Entresto 97 MG-103 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB26FU7VH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,617
Award facts
- Contract value 100% obligated
- $8,617.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entresto 97 mg-103 mg tablets (180-count supply) valued at $8,617.16 under a firm fixed price contract. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that authorizes AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's substantial IDC with DLA demonstrates its capability to meet stringent federal procurement requirements through competitive award processes and supports multiple customer entities including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Entresto, a cardiovascular medication, exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to support the Department of Defense's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB26FU7VH?
SPE2DB26FU7VH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FU7VH worth?
The government has obligated $8,617 on SPE2DB26FU7VH.
Is contract SPE2DB26FU7VH an order under another contract?
Yes. SPE2DB26FU7VH is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB26FU7VH competed?
The extent of competition for SPE2DB26FU7VH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award